ask="22.96"
ask_size="1000"
average_daily_volume="394482"
bid="20.75"
bid_size="200"
book_value="8.16"
change="+0.09"
change_from_200_day_moving_average="1.45"
change_from_50_day_moving_average="1.55"
change_from_52_week_high="-2.98"
change_From_52_week_low="9.99"
change_in_percent="+0.42%"
close="21.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-0.11"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.01"
ex_dividend_date="N/A"
float_shares="21374000"
high="22.36"
high_52_weeks="24.57"
last_trade_date="3/2/2017"
last_trade_price="21.59"
last_trade_size="32903"
last_trade_time="4:00pm"
low="20.25"
low_52_weeks="11.60"
market_capitalization="814.63M"
moving_average_200_day="20.14"
moving_average_50_day="20.04"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="20.45"
pe_ratio="N/A"
peg_ratio="-9.77"
percent_change_from_200_day_moving_average="+7.20%"
percent_change_from_50_day_moving_average="+7.74%"
percent_change_from_52_week_high="-12.13%"
percent_change_from_52_week_low="+86.12%"
previous_close="21.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.64"
price_per_sales="6.40"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.94"
stock_exchange="NGM"
symbol="RTRX"
volume="1770588"
weeks_range_52="11.60 - 24.57"
